Episode Details
Back to EpisodesThe First $100 Billion Drug
Episode 153
Published 3 years, 9 months ago
Description
BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.